Pashtoon Kasi/LinkedIn
Jan 27, 2025, 18:11
Pashtoon Kasi: Another trial unfortunately negative for patients with pancreas cancer
Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, shared on X:
“Another trial unfortunately negative for our patients with pancreas cancer.
As mentioned, innovation is needed.
The PanCAN is a great platform to study novel drugs. While mechanistically, Pamrevlumab was of value to study, it didn’t improve survival.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 25, 2025, 11:24
Feb 25, 2025, 11:23
Feb 25, 2025, 11:17
Feb 25, 2025, 11:15
Feb 25, 2025, 11:11
Feb 25, 2025, 11:04
Feb 25, 2025, 11:03
Feb 25, 2025, 10:56
Feb 25, 2025, 10:52
Feb 25, 2025, 10:52
Feb 25, 2025, 10:45